The DOI matches its Crossref record; 113 of the 114 references it cites were found in a registry or an index.
Chronic immune response dysregulation in MDS pathogenesis
Open accessAbstract
Chronic innate immune signaling in hematopoietic cells is widely described in myelodysplastic syndromes (MDS), and innate immune pathway activation, predominantly via pattern recognition receptors, increases the risk of developing MDS. An inflammatory component to MDS has been reported for many years, but only recently has evidence supported a more direct role of chronic innate immune signaling and associated inflammatory pathways in the pathogenesis of MDS. Here we review recent findings and discuss relevant questions related to chronic immune response dysregulation in MDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Human myelodysplastic syndrome (MDS) HSPCs have shown significant innate immune system dysregulation and resistance to the pro-proliferative effects of inflammation [69,80,81].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [80]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulated inflammatory signaling has emerged as a key partner alongside oncogenic mutations in the development and/or progression of hematological malignancy (Barreyro et al., 2018; Pietras, 2017).”
From PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress (2021) · cites this paper as Barreyro et al., 2018
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Chronic inflammation, often associated with increased IL-1 activity, is a common phenotype in individuals at risk for hematological malignancy, which can be related to several preexisting factors, including aging/tissue decline, genotoxin exposure, metabolic dysfunction, and/or autoimmune disease (Barreyro et al., 2018; Pietras, 2017).”
From PU.1 enforces quiescence and limits hematopoietic stem cell expansion during inflammatory stress (2021) · cites this paper as Barreyro et al., 2018
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Pyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,288
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683
WISEMAN, H., & HALLIWELL, B. (1996) · Biochemical Journal · doi:10.1042/bj3130017 · Cited by 2,345
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,141
The origin and evolution of mutations in acute myeloid leukemia
Welch, J. S., Ley, T. J., Link, D. C., Miller, C. A., Larson, D. E., Koboldt, D. C., Wartman, L. D., Lamprecht, T. L., Liu, F., Xia, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.023 · Cited by 1,575
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
Kaufmann, E., Sanz, J., Dunn, J. L., Khan, N., Mendonça, L. E., Pacis, A., Tzelepis, F., Pernet, E., Dumaine, A., Grenier, J.-C., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.031 · Cited by 1,191
Dnmt3a is essential for hematopoietic stem cell differentiation
Challen, G. A., Sun, D., Jeong, M., Luo, M., Jelinek, J., Berg, J. S., Bock, C., Vasanthakumar, A., Gu, H., Xi, Y., et al. (2012) · Nature Genetics · doi:10.1038/ng.1009 · Cited by 1,122
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Raaijmakers, M. H. G. P., Mukherjee, S., Guo, S., Zhang, S., Kobayashi, T., Schoonmaker, J. A., Ebert, B. L., Al-Shahrour, F., Hasserjian, R. P., Scadden, E. O., et al. (2010) · Nature · doi:10.1038/nature08851 · Cited by 1,115
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity
Mitroulis, I., Ruppova, K., Wang, B., Chen, L.-S., Grzybek, M., Grinenko, T., Eugster, A., Troullinaki, M., Palladini, A., Kourtzelis, I., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.034 · Cited by 1,100
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Zanoni, I., Ostuni, R., Marek, L. R., Barresi, S., Barbalat, R., Barton, G. M., Granucci, F., & Kagan, J. C. (2011) · Cell · doi:10.1016/j.cell.2011.09.051 · Cited by 997
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
Pang, W. W., Price, E. A., Sahoo, D., Beerman, I., Maloney, W. J., Rossi, D. J., Schrier, S. L., & Weissman, I. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116110108 · Cited by 991
Ehrchen, J. M., Sunderkötter, C. H., Foell, D., Vogl, T., & Roth, J. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008647 · Cited by 869
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
Boldin, M. P., Taganov, K. D., Rao, D. S., Yang, L., Zhao, J. L., Kalwani, M., Garcia-Flores, Y., Luong, M., Devrekanli, A., Xu, J., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101823 · Cited by 861
Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses
Lu, L.-F., Boldin, M. P., Chaudhry, A., Lin, L.-L., Taganov, K. D., Hanada, T., Yoshimura, A., Baltimore, D., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.08.012 · Cited by 849
Toll-like Receptors on Hematopoietic Progenitor Cells Stimulate Innate Immune System Replenishment
Nagai, Y., Garrett, K. P., Ohta, S., Bahrun, U., Kouro, T., Akira, S., Takatsu, K., & Kincade, P. W. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.008 · Cited by 833
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., et al. (2015) · Nature · doi:10.1038/nature15252 · Cited by 807
Association of Spindle Assembly Checkpoint Component XMAD2 with Unattached Kinetochores
Chen, R., Waters, J. C., Salmon, E. D., & Murray, A. W. (1996) · Science · doi:10.1126/science.274.5285.242 · Cited by 783
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Sano, S., Oshima, K., Wang, Y., MacLauchlan, S., Katanasaka, Y., Sano, M., Zuriaga, M. A., Yoshiyama, M., Goukassian, D., Cooper, M. A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.037 · Cited by 699
Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells
Walter, D., Lier, A., Geiselhart, A., Thalheimer, F. B., Huntscha, S., Sobotta, M. C., Moehrle, B., Brocks, D., Bayindir, I., Kaschutnig, P., et al. (2015) · Nature · doi:10.1038/nature14131 · Cited by 619
Human Toll-like receptor 4 recognizes host-specific LPS modifications
Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., & Miller, S. I. (2002) · Nature Immunology · doi:10.1038/ni777 · Cited by 579
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
Starczynowski, D. T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R., Muranyi, A., Hirst, M., Hogge, D., Marra, M., Wells, R. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2054 · Cited by 577
Self-citationLeukaemogenesis induced by an activating β-catenin mutation in osteoblasts
Kode, A., Manavalan, J. S., Mosialou, I., Bhagat, G., Rathinam, C. V., Luo, N., Khiabanian, H., Lee, A., Murty, V. V. V. S., Friedman, R. A., et al. (2014) · Nature · doi:10.1038/nature12883 · Cited by 551
Mechanism of action of lenalidomide in hematological malignancies
Kotla, V., Goel, S., Nischal, S., Heuck, C. J., Vivek, K., Das, B. C., & Verma, A. K. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-36 · Cited by 476
Jmjd3 contributes to the control of gene expression in LPS‐activated macrophages
Santa, F. D., Narang, V., Yap, Z. H., Tusi, B. K., Burgold, T., Austenaa, L. M. I., Bucci, G., Cagánová, M., Notarbartolo, S., Casola, S. S., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.271 · Cited by 433
Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host
Meisel, M., Hinterleitner, R., Pacis, A., Chen, L., Earley, Z. M., Mayassi, T., Pierre, J. F., Ernest, J. D., Galipeau, H. J., Thuille, N., et al. (2018) · Nature · doi:10.1038/s41586-018-0125-z · Cited by 406
Medyouf, H., Mossner, M., Jann, J.-C., Nolte, F., Raffel, S., Herrmann, C., Lier, A., Eisen, C., Nowak, V., Zens, B., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.014 · Cited by 399
NF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignancies
Zhao, J. L., Rao, D. S., Boldin, M. P., Taganov, K. D., O'Connell, R. M., & Baltimore, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105398108 · Cited by 386
Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment
Kovtonyuk, L. V., Fritsch, K., Feng, X., Manz, M. G., & Takizawa, H. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00502 · Cited by 371
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Basiorka, A. A., McGraw, K. L., Eksioglu, E. A., Chen, X., Johnson, J., Zhang, L., Zhang, Q., Irvine, B. A., Cluzeau, T., Sallman, D. A., et al. (2016) · Blood · doi:10.1182/blood-2016-07-730556 · Cited by 367
Zambetti, N. A., Ping, Z., Chen, S., Kenswil, K. J. G., Mylona, M. A., Sanders, M. A., Hoogenboezem, R. M., Bindels, E. M. J., Adisty, M. N., Van Strien, P. M. H., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.021 · Cited by 342
Chronic Exposure to a TLR Ligand Injures Hematopoietic Stem Cells
Esplin, B. L., Shimazu, T., Welner, R. S., Garrett, K. P., Nie, L., Zhang, Q., Humphrey, M. B., Yang, Q., Borghesi, L., & Kincade, P. W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003438 · Cited by 336
Benz, C., Copley, M. R., Kent, D. G., Wöhrer, S., Cortés, A., Aghaeepour, N., Ma, E., Mader, H., Rowe, K. M., Day, C. W., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.02.007 · Cited by 322
Gondek, L. P., Tiu, R. V., O’Keefe, C. L., Sekeres, M. A., Theil, K. S., & Maciejewski, J. P. (2007) · Blood · doi:10.1182/blood-2007-05-092304 · Cited by 318
Induction of myelodysplasia by myeloid-derived suppressor cells
Chen, X., Eksioglu, E. A., Zhou, J., Zhang, L., Djeu, J., Fortenbery, N., Epling-Burnette, P., Van Bijnen, S., Dolstra, H., Cannon, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67580 · Cited by 316
Müller‐Sieburg, C. E., Cho, R. H., Karlsson, L., Huang, J.-F., & Sieburg, H. B. (2004) · Blood · doi:10.1182/blood-2003-10-3448 · Cited by 309
Tet2 restrains inflammatory gene expression in macrophages
Cull, A. H., Snetsinger, B., Buckstein, R., Wells, R. A., & Rauh, M. J. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.08.001 · Cited by 295
Kristinsson, S. Y., Björkholm, M., Hultcrantz, M. L., Derolf, Å. R., Landgren, O., & Goldin, L. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8540 · Cited by 289
Takizawa, H., Fritsch, K., Kovtonyuk, L. V., Saito, Y., Yakkala, C., Jacobs, K., Ahuja, A. K., Lopes, M., Hausmann, A., Hardt, W., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.06.013 · Cited by 282
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
Pellagatti, A., Cazzola, M., Giagounidis, A. A. N., Perry, J., Malcovati, L., Porta, M. G. D., Jädersten, M., Killick, S. B., Verma, A. K., Norbury, C. J., et al. (2010) · Leukemia · doi:10.1038/leu.2010.31 · Cited by 279
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)
Kordasti, S. Y., Ingram, W. A., Hayden, J., Darling, D. C., Barber, L. D., Afzali, B., Lombardi, G., Włodarski, M. W., Maciejewski, J. P., Farzaneh, F., et al. (2007) · Blood · doi:10.1182/blood-2007-01-067546 · Cited by 279
Hepcidin regulation in the anemia of inflammation
Wang, C., & Babitt, J. L. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000236 · Cited by 261
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
Schneider, R. K., Schenone, M., Ferreira, M. S. V., Kramann, R., Joyce, C. E., Hartigan, C. R., Beier, F., Brümmendorf, T. H., Germing, U., Platzbecker, U., et al. (2016) · Nature Medicine · doi:10.1038/nm.4047 · Cited by 246
Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition
Akashi, S., Nagai, Y., Ogata, H., Oikawa, M., Fukase, K., Kusumoto, S., Kawasaki, K., Nishijima, M., Hayashi, S., Kimoto, M., et al. (2001) · International Immunology · doi:10.1093/intimm/13.12.1595 · Cited by 245
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
Gañán-Gómez, I., Wei, Y., Starczynowski, D. T., Colla, S., Yang, H., Cabrero-Calvo, M., Bohannan, Z. S., Verma, A., Steidl, U., & Garcia-Manero, G. (2015) · Leukemia · doi:10.1038/leu.2015.69 · Cited by 236
Self-citationCharacterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow
Hofmann, W., de Vos, S., Komor, M., Hoelzer, D. F., Wachsman, W., & Koeffler, H. P. (2002) · Blood · doi:10.1182/blood.v100.10.3553 · Cited by 235
DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells
Ohnishi, S., Ma, N., Thanan, R., Pinlaor, S., Hammam, O. A., Murata, M., & Kawanishi, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/387014 · Cited by 209
Li, X., Zhang, Q., Ding, Y., Liu, Y., Zhao, D., Zhao, K., Shen, Q., Liu, X., Zhu, X., Li, N., et al. (2016) · Nature Immunology · doi:10.1038/ni.3464 · Cited by 206
Species-specific Regulation of Toll-like Receptor 3 Genes in Men and Mice
Heinz, S., Haehnel, V., Karaghiosoff, M., Schwarzfischer, L., Müller, M., Krause, S. W., & Rehli, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301476200 · Cited by 202
Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome
Rhyasen, G. W., Bolanos, L., Fang, J., Jerez, A., Wunderlich, M., Rigolino, C., Mathews, L., Ferrer, M., Southall, N., Guha, R., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.006 · Cited by 199
Self-citationMacrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3
Zhang, X., Wang, Y., Yuan, J., Li, N., Pei, S., Xu, J., Luo, X., Mao, C., Liu, J., Yu, T., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171417 · Cited by 195
Xing, Y., Yao, X., Li, H., Xue, G., Guo, Q., Yang, G., An, L., Zhang, Y., & Meng, G. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700175 · Cited by 181
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations
Inoue, D., Kitaura, J., Togami, K., Nishimura, K., Enomoto, Y., Uchida, T., Kagiyama, Y., Kawabata, K. C., Nakahara, F., Izawa, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70739 · Cited by 179
Stem cell heterogeneity: implications for aging and regenerative medicine
Müller‐Sieburg, C. E., Sieburg, H. B., Bernitz, J. M., & Cattarossi, G. (2012) · Blood · doi:10.1182/blood-2011-12-376749 · Cited by 164
Sioud, M., Fløisand, Y., Forfang, L., & Lund‐Johansen, F. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.054 · Cited by 160
Kornblau, S. M., McCue, D. L., Singh, N., Chen, W., Estrov, Z. E., & Coombes, K. R. (2010) · Blood · doi:10.1182/blood-2010-01-262071 · Cited by 160
Toll-like receptor alterations in myelodysplastic syndrome
Wei, Y., Dimicoli, S., Bueso‐Ramos, C. E., Chen, R., Yang, H., Neuberg, D. S., Pierce, S. A., Jia, Y., Zheng, H., Wang, H., et al. (2013) · Leukemia · doi:10.1038/leu.2013.180 · Cited by 159
Kotsianidis, Ι., Bouchliou, I., Nakou, E., Spanoudakis, E., Margaritis, D., Christophoridou, A. V., Anastasiades, A., Tsigalou, C., Bourikas, G., Karadimitris, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.333 · Cited by 147
Maratheftis, C. I., Andreakos, E., Moutsopoulos, H. Μ., & Voulgarelis, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2108 · Cited by 140
Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes
Feng, X., Scheinberg, P., Wu, C. O., Samsel, L., Nunez, O., Prince, C. J., Ganetzky, R. D., McCoy, J. P., Maciejewski, J. P., & Young, N. S. (2010) · Haematologica · doi:10.3324/haematol.2010.030536 · Cited by 137
Kittang, A. O., Kordasti, S. Y., Sand, K. E., Costantini, B., Kramer, A. M., Abellan, P. P., Seidl, T., Rye, K. P., Hagen, K. M., Kulasekararaj, A. G., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1062208 · Cited by 132
Luca, K. D., Frances-Duvert, V., Asensio, M.-J., Ihsani, R., Debien, E., Taillardet, M., Verhoeyen, E., Bella, C., Lantheaume, S., Genestier, L., et al. (2009) · Leukemia · doi:10.1038/leu.2009.155 · Cited by 129
Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations
Starczynowski, D. T., Morin, R. D., McPherson, A., Lam, J., Chari, R., Węgrzyn, J., Kuchenbauer, F. C., Hirst, M., Tohyama, K., Humphries, R. K., et al. (2010) · Blood · doi:10.1182/blood-2010-03-277012 · Cited by 125
Self-citationÅgerstam, H., Karlsson, C., Hansen, N., Sandén, C., Askmyr, M., von Palffy, S., Högberg, C., Rissler, M., Wunderlich, M., Juliusson, G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422749112 · Cited by 111
Varney, M. E., Niederkorn, M., Konno, H., Matsumura, T., Gohda, J., Yoshida, N., Akiyama, T., Christie, S., Fang, J., Miller, D., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141898 · Cited by 111
Self-citationCoordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q− syndrome
Kumar, M. S., Narla, A., Nonami, A., Mullally, A., Dimitrova, N., Ball, B. J., McAuley, J. R., Poveromo, L., Kutok, J. L., Galili, N., et al. (2011) · Blood · doi:10.1182/blood-2010-12-324715 · Cited by 110
Ma, S., Wan, X., Deng, Z., Shi, L., Hao, C., Zhou, Z., Zhou, C., Fang, Y., Liu, J., Yang, J. C., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161149 · Cited by 110
Santamaría, C., Muntión, S., Rosón, B., Blanco, B., López‐Villar, O., Carrancio, S., Sanchez-Guijo, F. M., Díez‐Campelo, M., Álvarez-Fernández, S., Sarasquete, M. E., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.054437 · Cited by 109
HSC Aging and Senescent Immune Remodeling
Denkinger, M. D., Leins, H., Schirmbeck, R., Florian, M. C., & Geiger, H. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.10.008 · Cited by 107
Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance.
Swafford, D., & Manicassamy, S. (2015) · PubMed · Cited by 104
Chen, X., Deng, H., Churchill, M., Luchsinger, L. L., Du, X., Chu, T. H., Friedman, R. A., Middelhoff, M. A., Ding, H., Tailor, Y. H., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.11.003 · Cited by 103
Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia
Fang, J., Bolanos, L. C., Choi, K., Liu, X., Christie, S., Akunuru, S., Kumar, R., Wang, D., Chen, X., Greis, K. D., et al. (2016) · Nature Immunology · doi:10.1038/ni.3654 · Cited by 100
Self-citationWang, C., Yan, Y., Gao, S., Chen, J., Yu, J., Zhang, H., Li, M., Zhan, X., & Li, W. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.12.013 · Cited by 95
Wei, Y., Chen, R., Dimicoli, S., Bueso‐Ramos, C. E., Neuberg, D. S., Pierce, S. A., Wang, H., Yang, H., Jia, Y., Zheng, H., et al. (2013) · Leukemia · doi:10.1038/leu.2013.91 · Cited by 84
Pardanani, A. D., Finke, C. M., Lasho, T. L., Al‐Kali, A., Begna, K. H., Hanson, C. A., & Tefferi, A. (2011) · Leukemia · doi:10.1038/leu.2011.251 · Cited by 82
TRAF6 Mediates Basal Activation of NF-κB Necessary for Hematopoietic Stem Cell Homeostasis
Fang, J., Muto, T., Kleppe, M., Bolanos, L. C., Hueneman, K. M., Walker, C. S., Sampson, L. L., Wellendorf, A. M., Chetal, K., Choi, K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.013 · Cited by 79
Self-citationBoiko, J. R., & Borghesi, L. (2011) · Cytokine · doi:10.1016/j.cyto.2011.10.005 · Cited by 78
Zhang, H., Hu, H., Greeley, N. R., Jin, J., Matthews, A. J., Ohashi, E., Caetano, M. S., Li, H. S., Wu, X., Mandal, P. K., et al. (2014) · Nature Communications · doi:10.1038/ncomms6798 · Cited by 76
Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes
Sokol, L., Cáceres, G., Volinia, S., Alder, H., Nuovo, G. J., Liu, C., McGraw, K. L., Clark, J., Sigua, C. A., Chen, D., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08581.x · Cited by 74
Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation
Bhagat, T. D., Chen, S., Bartenstein, M., Barlowe, A. T., Ahrens, D. V., Choudhary, G. S., Tivnan, P., Amin, E. M., Marcondes, A. M., Sanders, M. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0282 · Cited by 74
Dimicoli, S., Wei, Y., Bueso-Ramos, C., Yang, H., Dinardo, C. D., Jia, Y., Zheng, H., Fang, Z., Nguyen, M. H., Pierce, S. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071120 · Cited by 72
Mei, Y., Zhao, B., Basiorka, A. A., Yang, J. C., Cao, L., Zhang, J., List, A. F., & Ji, P. (2017) · Leukemia · doi:10.1038/leu.2017.326 · Cited by 72
TLRs control hematopoiesis during infection
Yáñez, A., Goodridge, H. S., Gozalbo, D., & Gil, M. L. (2013) · European Journal of Immunology · doi:10.1002/eji.201343833 · Cited by 68
Eksioglu, E. A., Chen, X., Heider, K.-H., Rueter, B., McGraw, K. L., Basiorka, A. A., Wei, M., Burnette, A., Cheng, P., Lancet, J., et al. (2017) · Leukemia · doi:10.1038/leu.2017.21 · Cited by 66
Oduro, K. A., Liu, F., Tan, Q., Kim, C. K., Lubman, O., Fremont, D. H., Mills, J. C., & Choi, K. (2012) · Blood · doi:10.1182/blood-2011-11-391342 · Cited by 65
Fang, J., Barker, B., Bolanos, L. C., Liu, X., Jerez, A., Makishima, H., Christie, S., Chen, X., Rao, D. S., Grimes, H. L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.062 · Cited by 65
Self-citationHematopoietic Stem and Progenitor Cells as Effectors in Innate Immunity
Granick, J. L., Simon, S. I., & Borjesson, D. L. (2012) · Bone Marrow Research · doi:10.1155/2012/165107 · Cited by 61
Bone marrow lympho-myeloid malfunction in obesity requires precursor cell-autonomous TLR4
Liu, A., Chen, M., Kumar, R. J., Stefanović-Račić, M., O'Doherty, R. M., Ding, Y., Jahnen‐Dechent, W., & Borghesi, L. (2018) · Nature Communications · doi:10.1038/s41467-018-03145-8 · Cited by 59
Zhao, Y., Wu, D., Fei, C., Guo, J., Gu, S., Zhu, Y., Xu, F., Zhang, Z.-L., Wu, L., Li, X., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.109769 · Cited by 55
Herman, A., Monlish, D. A., Romine, M. P., Bhatt, S. T., Zippel, S., & Schuettpelz, L. G. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.45 · Cited by 55
Kerbauy, D. M. B., Lesnikov, V. A., Torok‐Storb, B., Bryant, E. M., & Deeg, H. J. (2004) · Blood · doi:10.1182/blood-2004-04-1518 · Cited by 55
Keerthivasan, G., Mei, Y., Zhao, B., Zhang, L., Harris, C. E., Gao, J., Basiorka, A. A., Schipma, M. J., McElherne, J., Yang, J. C., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552463 · Cited by 54
Wu, X., Bekker-Jensen, I. H., Christensen, J. F., Rasmussen, K. D., Sidoli, S., Qi, Y., Kong, Y., Wang, X., Cui, Y., Xiao, Z., et al. (2015) · Cell Research · doi:10.1038/cr.2015.121 · Cited by 50
Lam, J., van den Bosch, M. T. J., Węgrzyn, J., Parker, J., Ibrahim, R., Slowski, K., Chang, L., Martínez-Høyer, S., Condorelli, G., Boldin, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04831-3 · Cited by 44
Repressing the repressor: Ezh2 mediates macrophage activation
Neele, A. E., & de Winther, M. P. J. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180479 · Cited by 41
Ziegler, P., Boettcher, S., Takizawa, H., Manz, M. G., & Brümmendorf, T. H. (2015) · Annals of Hematology · doi:10.1007/s00277-015-2550-5 · Cited by 40
Deconstructing innate immune signaling in myelodysplastic syndromes
Varney, M. E., Melgar, K., Niederkorn, M., Smith, M. A., Barreyro, L., & Starczynowski, D. T. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.016 · Cited by 38
Self-citationBone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes
Saft, L., Björklund, E., Berg, E., Hellström‐Lindberg, E., & Porwit‐MacDonald, A. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.10.010 · Cited by 38
Establishment of a xenograft model of human myelodysplastic syndromes
Muguruma, Y., Matsushita, H., Yahata, T., Yumino, S., Tanaka, Y., Miyachi, H., Ogawa, Y., Kawada, H., Ito, M., & Ando, K. (2010) · Haematologica · doi:10.3324/haematol.2010.027557 · Cited by 38
Enhancer of Zeste Homolog 2 Is a Negative Regulator of Mitochondria-Mediated Innate Immune Responses
Chen, S., Sheng, C., Liu, D., Yao, C., Gao, S., Song, L., Jiang, W., Li, J., & Huang, W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203143 · Cited by 37
IL10 inversely correlates with the percentage of CD8+ cells in MDS patients
Lopes, M. R., Traina, F., Campos, P. D. M., Pereira, J. K. N., Machado‐Neto, J. A., Machado, H. D. C., Gilli, S. C. O., Saad, S. T. O., & Favaro, P. M. B. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.01.019 · Cited by 33
Monocyte-Derived Macrophages Are Impaired in Myelodysplastic Syndrome
Han, Y., Wang, H., & Shao, Z. (2016) · Journal of Immunology Research · doi:10.1155/2016/5479013 · Cited by 32
Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome
Varney, M. E., Choi, K., Bolanos, L. C., Christie, S., Fang, J., Grimes, H. L., Maciejewski, J., Inoue, J.-I., & Starczynowski, D. T. (2016) · Leukemia · doi:10.1038/leu.2016.276 · Cited by 30
Self-citationZeng, Q., Shu, J. S., Hu, Q., Shao-hong, Z., Qian, Y., Hu, M., Hu, L., Wang, Y., Zhou, Y., & Lü, J. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.12.008 · Cited by 29
Moudrá, A., Hubáčková, S., Machalová, V., Vančurová, M., Bártek, J., Reiniš, M., Hodný, Z., & Jonasova, A. T. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1183860 · Cited by 27
Stoddart, A., Qian, Z. Y., Fernald, A. A., Bergerson, R. J., Wang, J., Karrison, T. G., Anastasi, J., Bartom, E. T., Sarver, A. L., McNerney, M. E., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.139527 · Cited by 20
Down-regulation of EZH2 expression in myelodysplastic syndromes
Cabrero, M., Wei, Y., Yang, H., Gañán‐Gómez, I., Bohannan, Z., Colla, S., Marchesini, M., Bravo, G. M., Takahashi, K., Bueso-Ramos, C., et al. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.02.009 · Cited by 18
Monlish, D. A., Bhatt, S. T., Duncavage, E. J., Greenberg, Z. J., Keller, J. L., Romine, M. P., Yang, W., Aplan, P. D., Walter, M. J., & Schuettpelz, L. G. (2018) · Blood · doi:10.1182/blood-2017-08-801944 · Cited by 14
Kim, H., Lee, S., & Lee, S. (2018) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2018.0191 · Cited by 7
Fang, J., Bolanos, L. C., Choi, K., Liu, X., Christie, S., Akunuru, S., Kumar, R., Wang, D., Chen, X., Greis, K. D., et al. (2017) · Nature Immunology · doi:10.1038/ni0417-474a · Cited by 5
Self-citation
Cited by
Sorted by citations
Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling
Hormaechea-Agulla, D., Matatall, K. A., Le, D. T., Kain, B., Long, X., Kus, P., Jaksik, R., Challen, G. A., Kimmel, M., & King, K. Y. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.03.002 · Cited by 329
Inflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata‐Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 319
The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes
Sallman, D. A., & List, A. (2019) · Blood · doi:10.1182/blood-2018-10-844654 · Cited by 273
Smith, M. A., Choudhary, G. S., Pellagatti, A., Choi, K., Bolanos, L. C., Bhagat, T. D., Gordon-Mitchell, S., Ahrens, D. V., Pradhan, K., Steeples, V., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0314-5 · Cited by 253
Self-citationInnate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS
Trowbridge, J. J., & Starczynowski, D. T. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201544 · Cited by 189
Self-citation
Metadata
- Authors
- Barreyro, L., Chlon, T. M., & Starczynowski, D. T.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Barreyro, Laura
- Chlon, Timothy M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2018-10-11
- Volume
- 132
- Issue
- 15
- Pages
- 1553-1560
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC6182269
- OpenAlex
- W2885816375
- Cited by
- 226
- References
- 114
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 28 · 2023: 26 · 2022: 43 · 2021: 35 · 2020: 23 · 2019: 23 · 2018: 1
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Society of Hematology
- Leukemia and Lymphoma Society
- Cincinnati Children's Hospital Medical Center
- National Institutes of Health (1f32hl143993-01, RO1DK102759)
- National Heart, Lung, and Blood Institute (R35HL135787, F32 HL143993)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK102759, RO1DK102759, R01DK113639)
- National Institute of Environmental Health Sciences (T32ES007250)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- myelodysplastic syndrome, innate immune signaling, pattern recognition receptors, inflammation, hematopoietic cells, MDS pathogenesis
- MeSH terms
- Animals, Hematopoietic Stem Cells, Humans, Immunity, Innate, Inflammation, Myelodysplastic Syndromes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
